Merck
MRK
#47
Rank
A$461.04 B
Marketcap
A$186.67
Share price
3.34%
Change (1 day)
49.02%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.49

According to Merck's latest financial reports the company's current EPS (TTM) is A$5.13. In 2025 the company made an earnings per share (EPS) of A$10.50 an increase over its 2024 EPS that were of A$9.74.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.49-47.74%
2025A$10.507.81%
2024A$9.744308.46%
2023A$0.22-97.32%
2022A$8.2610.92%
2021A$7.4484.68%
2020A$4.03-27.2%
2019A$5.5463.44%
2018A$3.39151.11%
2017A$1.35-54.58%
2016A$2.9730.21%
2015A$2.28-61.99%
2014A$6.00180.51%
2013A$2.14-31.82%
2012A$3.146.62%
2011A$2.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.59 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.11 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.89-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.20 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.67 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.86 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.69-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.13 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.60 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.97-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel